327 related articles for article (PubMed ID: 11104787)
1. Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.
Hattori N; Degen JL; Sisson TH; Liu H; Moore BB; Pandrangi RG; Simon RH; Drew AF
J Clin Invest; 2000 Dec; 106(11):1341-50. PubMed ID: 11104787
[TBL] [Abstract][Full Text] [Related]
2. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system.
Swaisgood CM; French EL; Noga C; Simon RH; Ploplis VA
Am J Pathol; 2000 Jul; 157(1):177-87. PubMed ID: 10880388
[TBL] [Abstract][Full Text] [Related]
3. PAI-1, fibrosis, and the elusive provisional fibrin matrix.
Loskutoff DJ; Quigley JP
J Clin Invest; 2000 Dec; 106(12):1441-3. PubMed ID: 11120750
[No Abstract] [Full Text] [Related]
4. The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism.
Hattori N; Mizuno S; Yoshida Y; Chin K; Mishima M; Sisson TH; Simon RH; Nakamura T; Miyake M
Am J Pathol; 2004 Mar; 164(3):1091-8. PubMed ID: 14982862
[TBL] [Abstract][Full Text] [Related]
5. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene.
Eitzman DT; McCoy RD; Zheng X; Fay WP; Shen T; Ginsburg D; Simon RH
J Clin Invest; 1996 Jan; 97(1):232-7. PubMed ID: 8550840
[TBL] [Abstract][Full Text] [Related]
6. Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.
Fujimoto H; Gabazza EC; Taguchi O; Nishii Y; Nakahara H; Bruno NE; D'Alessandro-Gabazza CN; Kasper M; Yano Y; Nagashima M; Morser J; Broze GJ; Suzuki K; Adachi Y
Am J Pathol; 2006 Apr; 168(4):1086-96. PubMed ID: 16565485
[TBL] [Abstract][Full Text] [Related]
7. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
[TBL] [Abstract][Full Text] [Related]
8. Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse.
Olman MA; Mackman N; Gladson CL; Moser KM; Loskutoff DJ
J Clin Invest; 1995 Sep; 96(3):1621-30. PubMed ID: 7544811
[TBL] [Abstract][Full Text] [Related]
9. Localization of plasminogen activator activity within normal and injured lungs by in situ zymography.
Nishiuma T; Sisson TH; Subbotina N; Simon RH
Am J Respir Cell Mol Biol; 2004 Nov; 31(5):552-8. PubMed ID: 15284078
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin-induced lung injury support alveolar fibrin deposition.
Idell S; James KK; Gillies C; Fair DS; Thrall RS
Am J Pathol; 1989 Aug; 135(2):387-99. PubMed ID: 2476934
[TBL] [Abstract][Full Text] [Related]
11. Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice.
Sisson TH; Hanson KE; Subbotina N; Patwardhan A; Hattori N; Simon RH
Am J Physiol Lung Cell Mol Physiol; 2002 Nov; 283(5):L1023-32. PubMed ID: 12376355
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
[TBL] [Abstract][Full Text] [Related]
13. A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice.
Ploplis VA; Wilberding J; McLennan L; Liang Z; Cornelissen I; DeFord ME; Rosen ED; Castellino FJ
Am J Pathol; 2000 Sep; 157(3):703-8. PubMed ID: 10980108
[TBL] [Abstract][Full Text] [Related]
14. The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice.
Courey AJ; Horowitz JC; Kim KK; Koh TJ; Novak ML; Subbotina N; Warnock M; Xue B; Cunningham AK; Lin Y; Goldklang MP; Simon RH; Lawrence DA; Sisson TH
Blood; 2011 Aug; 118(8):2313-21. PubMed ID: 21734232
[TBL] [Abstract][Full Text] [Related]
15. The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice.
Bauman KA; Wettlaufer SH; Okunishi K; Vannella KM; Stoolman JS; Huang SK; Courey AJ; White ES; Hogaboam CM; Simon RH; Toews GB; Sisson TH; Moore BB; Peters-Golden M
J Clin Invest; 2010 Jun; 120(6):1950-60. PubMed ID: 20501949
[TBL] [Abstract][Full Text] [Related]
16. The antifibrinolytic drug tranexamic acid reduces liver injury and fibrosis in a mouse model of chronic bile duct injury.
Joshi N; Kopec AK; Towery K; Williams KJ; Luyendyk JP
J Pharmacol Exp Ther; 2014 Jun; 349(3):383-92. PubMed ID: 24633426
[TBL] [Abstract][Full Text] [Related]
17. Treatment of bleomycin-induced pulmonary fibrosis by transfer of urokinase-type plasminogen activator genes.
Sisson TH; Hattori N; Xu Y; Simon RH
Hum Gene Ther; 1999 Sep; 10(14):2315-23. PubMed ID: 10515451
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 deficiency augments visceral mesothelial organization, intrapleural coagulation, and lung restriction in mice with carbon black/bleomycin-induced pleural injury.
Tucker TA; Jeffers A; Alvarez A; Owens S; Koenig K; Quaid B; Komissarov AA; Florova G; Kothari H; Pendurthi U; Mohan Rao LV; Idell S
Am J Respir Cell Mol Biol; 2014 Feb; 50(2):316-27. PubMed ID: 24024554
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen-mediated activation and release of hepatocyte growth factor from extracellular matrix.
Matsuoka H; Sisson TH; Nishiuma T; Simon RH
Am J Respir Cell Mol Biol; 2006 Dec; 35(6):705-13. PubMed ID: 16840775
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor-1 promotes the proliferation and inhibits the apoptosis of pulmonary fibroblasts by Ca(2+) signaling.
Zhang YP; Wang WL; Liu J; Li WB; Bai LL; Yuan YD; Song SX
Thromb Res; 2013 Jan; 131(1):64-71. PubMed ID: 23021499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
